Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Müller-Lissner

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Deutsches Arzteblatt International|July 23, 2009
The pathophysiology, diagnosis, and treatment of constipationStefan Müller-Lissner
European Journal of Gastroenterology & Hepatology|April 12, 2006
"My patients are the sickest"Stefan Müller-Lissner
Expert Opinion on Drug Metabolism & Toxicology|February 22, 2013
Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatmentsStefan Müller-Lissner
Deutsche Medizinische Wochenschrift (1946)|August 16, 2019
[Constipation - pathophysiology, diagnostics, treatment]Stefan Müller-Lissner
Best Practice & Research. Clinical Gastroenterology|April 30, 2002
General geriatrics and gastroenterology: constipation and faecal incontinenceStefan Müller-Lissner
Best Practice & Research. Clinical Gastroenterology|June 5, 2007
The difficult patient with constipationStefan Müller-Lissner
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 14, 2009
Treatment of chronic constipation: current pharmacologic approaches and future directionsJan Tack, Stefan Müller-Lissner
The British Journal of Nutrition|September 19, 2015
Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trialDorte Eskesen, Lillian Jespersen, Birgit Michelsen, et al.
The American Journal of Gastroenterology|November 9, 2006
Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipationStefan Müller-Lissner, Michael A Kamm, Ahmet Musoglu, et al.
Journal of Clinical Epidemiology|May 28, 2003
Subject's Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trialsStefan Müller-Lissner, Gary Koch, Nicholas J Talley, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Deutsches Arzteblatt International|July 23, 2009
The pathophysiology, diagnosis, and treatment of constipationStefan Müller-Lissner
European Journal of Gastroenterology & Hepatology|April 12, 2006
"My patients are the sickest"Stefan Müller-Lissner
Expert Opinion on Drug Metabolism & Toxicology|February 22, 2013
Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatmentsStefan Müller-Lissner
Deutsche Medizinische Wochenschrift (1946)|August 16, 2019
[Constipation - pathophysiology, diagnostics, treatment]Stefan Müller-Lissner
Best Practice & Research. Clinical Gastroenterology|April 30, 2002
General geriatrics and gastroenterology: constipation and faecal incontinenceStefan Müller-Lissner
Best Practice & Research. Clinical Gastroenterology|June 5, 2007
The difficult patient with constipationStefan Müller-Lissner
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 14, 2009
Treatment of chronic constipation: current pharmacologic approaches and future directionsJan Tack, Stefan Müller-Lissner
The British Journal of Nutrition|September 19, 2015
Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trialDorte Eskesen, Lillian Jespersen, Birgit Michelsen, et al.
The American Journal of Gastroenterology|November 9, 2006
Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipationStefan Müller-Lissner, Michael A Kamm, Ahmet Musoglu, et al.
Journal of Clinical Epidemiology|May 28, 2003
Subject's Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trialsStefan Müller-Lissner, Gary Koch, Nicholas J Talley, et al.
Pageof 2